Hyloris Elargit son Portefeuille de Produits avec un Nouveau Produit Candidat pour le Lichen Scléreux Vulvaire (LSV)
January 18, 2024 13:00 ET
|
Hyloris Pharmaceuticals SA
Co-Partenariat avec AFT Pharmaceuticals pour le Développement d'un Film Muco-adhésif Libérant des Médicaments pour le LSV (HY-091)Disponibilité Limitée des Options Thérapeutiques Approuvées dans les...
Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)
January 18, 2024 13:00 ET
|
Hyloris Pharmaceuticals SA
Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS) Equal Partnership with AFT Pharmaceuticals for Development of a Drug Releasing Mucoadhesive Film for VLS...
Global Women’s Healthcare Market Set to Witness Spells of Growth—Projected to Reach USD 46,163.5 Million by 2027
July 15, 2021 08:28 ET
|
BlueWeave Consulting and Research Pvt Ltd
Noida, India, July 15, 2021 (GLOBE NEWSWIRE) -- A study recently conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global women’s healthcare...
ACTION BEHAVIOR CENTERS PARTNERS WITH NURX TO OFFER ENHANCED HEALTH BENEFITS TO ITS EMPLOYEES
May 18, 2021 10:00 ET
|
Action Behavior Centers
Austin, Texas, May 18, 2021 (GLOBE NEWSWIRE) -- Action Behavior Centers (ABC), a leading provider of Applied Behavior Analysis (ABA) therapy for children with Autism, today, announced an innovative...